© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
Dr. Peter Attia Discusses CVS Pharmacy Blocking Fluvoxamine for Treating Covid-19
282 views • 01/09/2022
Dr. Peter Attia Discusses CVS Pharmacy Blocking Fluvoxamine for Treating Covid-19
"A JAMA study published in November of last year suggested that it had enormous efficacy in treating covid. A more rigorous trial was published in JAMA last month. That study included about 1,500 subjects evenly split and randomized to either a placebo or 100 mg of fluvoxamine twice a day for ten days...
The results were so overwhelming that the study was stopped prematurely. It resulted in a 66% reduction in hospitalization and a 91% reduction in death... When you consider this study and the previous study it seems pretty clear to me that fluvoxamine is a no-brainer when you are talking about treating patients with covid."
"A JAMA study published in November of last year suggested that it had enormous efficacy in treating covid. A more rigorous trial was published in JAMA last month. That study included about 1,500 subjects evenly split and randomized to either a placebo or 100 mg of fluvoxamine twice a day for ten days...
The results were so overwhelming that the study was stopped prematurely. It resulted in a 66% reduction in hospitalization and a 91% reduction in death... When you consider this study and the previous study it seems pretty clear to me that fluvoxamine is a no-brainer when you are talking about treating patients with covid."
Keywords
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.
